Pfizer Ends Studies on Drug for Treating Heart Disease
65762
The stunning announcement is likely to damage the companyÂs prospects for decades as research linked the drug to deaths and heart problems.
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
511798
A government-sponsored trial of Pfizer Inc.'s  blockbuster arthritis drug Celebrex was halted after patients taking the medicine had more than twice as many heart attacks as patients taking a placebo, the company said on Friday.
240625
Pfizer Inc. said on Monday it plans to sponsor a major clinical study to further assess the cardiovascular safety of its arthritis drug Celebrex following the withdrawal of Merck & Co.'s Vioxx, a drug in the same class.
409429
A new drug from Sanofi-Aventis reduced significantly episodes of atrial fibrillaton or irregular heart beat in two clinical studies released on Sunday.
308611
Investors dumped shares of Pfizer Inc. today in response to the drug giant's weekend announcement that it has halted development of a potential blockbuster cholesterol treatment.
203289
Germany's drug regulator on Monday  told patients with cardiovascular risks to stop using Pfizer's  arthritis drug Celebrex after new data emerged linking it to an  elevated risk of heart attacks.
411818
A drug combination that produced such positive results in clinical trials that they were stopped before their scheduled completion date reduces death from coronary heart disease by up to 43 percent, a new study reports.
85822
Pfizer plans to immediately stop advertising Celebrex, its best-selling arthritis pain reliever, to consumers after a study linked it to an increased risk of heart attacks.
382436
Drug giant Pfizer Inc. reiterated Thursday that its arthritis drug Celebrex was safe to use after competitor Merck &amp; Co. pulled its arthritis drug Vioxx off the market worldwide after studies showed it raised the risk of heart attack.
704534
Bayer HealthCare, a U.S.-based unit of Bayer AG  , stopped a late-stage trial of Nexavar in patients  with non-small cell lung cancer, after an independent data  monitoring committee concluded that the study would not meet  the main goal of improved overall survival.
74465
Pharmaceutical giant Pfizer Inc. said Wednesday that a long-term study of its Norvasc blood pressure treatment in patients with other heart disease risks was stopped early because of the drug&#39;s significant benefits.
86750
A prescription painkiller used by more than 250,000 Australians to treat arthritis has been withdrawn from sale after a clinical trial found it doubled the risk of heart attack and stroke.
625109
Doctors writing in a prominent medical  journal on Friday recommended that physicians stop prescribing  Pfizer Inc.'s Bextra painkiller, just as a large study found  the drug maker's sister drug, Celebrex, doubled risk of heart  attacks.
365287
Kaiser Permanente has stopped dispensing Bextra, an arthritis and pain drug made by Pfizer that may increase the risk of heart attacks and strokes.
223257
Pfizer Inc. has agreed to suspend  its advertisements for arthritis drug Celebrex while U.S.  regulators review new data that link the drug to an elevated  risk of heart attacks, a Food and Drug Administration  spokeswoman said on Sunday.
729710
Citing the &quot;interests of patient safety,&quot; US drug manufacturer Pfizer said it was stopping all clinical trials of the cholesterol-controlling drug Torcetrapib.